株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

CRISPR/Cas9ゲノム編集製品の世界市場 (2017年)

The 2017 Market for CRISPR/Cas9 Genome Editing Products

発行 BioInformatics Inc. 商品コード 566779
出版日 ページ情報 英文 85 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.32円で換算しております。
Back to Top
CRISPR/Cas9ゲノム編集製品の世界市場 (2017年) The 2017 Market for CRISPR/Cas9 Genome Editing Products
出版日: 2017年08月31日 ページ情報: 英文 85 Pages
概要

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) は単純ながら強力なゲノム編集手法で、近年になって科学研究の世界に大きな衝撃をもたらしました。Cas9タンパク質との組み合わせで、ヒト・動物・植物のDNAに特定の変化 (追加・修正・除去) を施すことが可能で、農業やバイオテクノロジーの世界に巨大な変革を起こす可能性を秘めています。2021年には、CRISPR/Cas9関連市場は36億1000万米ドルの規模に達すると見込まれています。

当レポートでは、CRISPR/Cas9ゲノム編集 (遺伝子編集) ツールや関連サービスの世界市場について分析し、技術の概要や市場の基本構造、市場規模・価格水準の推移と見通し、今後の技術進歩・市場成長の可能性などについて調査しております。

市場分析:

  • 研究所のおおよその規模とCRISPR/Cas9製品やサービスの購入に使われる年間予算
  • CRISPR/Cas9製品やサービスに対する研究所の支出という観点から見た供給企業への「予算配分」
  • 今後12ヶ月間の予算の動向を踏まえた市場の成長見通し

ワークフロー分析:

  • ゲノム編集実験の経験年数
  • 最も多く採用されている実験モデルシステム
  • CRISPR/Cas9ゲノム編集実験に関連する研究の焦点 (診断法、治療法、基礎研究、創薬など)
  • Cas9タンパク質とガイドRNAの発現にとって望ましい製品構成
  • CRISPR実験を構成する要素の定義
  • 現在行われているCRISPR/Cas9実験のレベルと、今後12ヶ月間に予想されるスループットの変化
  • ガイドRNAを生成するDNAやRNAの設計に適したソフトウェアソリューション
  • 対象となる細胞や標的にCas9タンパク質とガイドRNAフォーマットを誘導するため用いられる分子移動法
  • 新規Cas9タンパク質の利用

ブランド分析:

  • CRISPR/Cas9製品やサービスの供給企業の認知度と利用状況
  • CRISPR/Cas9製品やサービスの供給企業に対する顧客の満足度
  • 供給企業各社のブランドの実績に対する顧客の評価

顧客分析:

  • ゲノム編集実験を行う動機
  • CRISPR/Cas9製品に対する顧客の満足度
  • 個々の供給企業のCRISPR/Cas9製品の実績に対する顧客の評価
  • 顧客がCRISPR/Cas9製品やサービスの供給企業を推奨する可能性
  • 顧客がCRISPR/Cas9製品やサービスを再度購入する可能性
  • 顧客がCRISPR/Cas9製品やサービスの主な供給企業を切り替える可能性
  • 主な供給企業を切り替える動機
目次
Product Code: 17-004

Clustered Regularly Interspaced Short Palindromic Repeats, or more popularly "CRISPR", is a simple yet powerful genome editing technique that has recently taken the scientific community by storm. When coupled with the Cas9 protein, the technology allows for specific changes (addition, modification and deletions) to be made to the DNA of humans, animals, and plants, thereby offering a tremendous amount of potential in a wide array of applications ranging from agriculture biotechnology to therapeutics.

Cas9 variants have become an important means by which suppliers differentiate themselves from each other. Furthermore, because of the nascent nature of the technology, numerous variations on the CRISPR/Cas9 system are likely still waiting to be developed and patented, leaving the door open for suppliers to broaden their CRISPR/Cas9 product offerings. Consequently, the genome editing market, of which CRISPR/Cas9 already accounts for more than half, is poised to expand rapidly over the coming years. By 2021, the market for CRISPR/Cas9 is expected to reach $3.61 billion in annual revenue .

The majority of research scientists rely on the products and services of AddGene, Integrated DNA Technologies (IDT) and Thermo Fisher Scientific for their CRISPR/Cas9 research. However, the market is extremely fragmented, with numerous smaller companies vying for market share. More than 50% of the market is comprised of companies that hold only 8% or less market share .

For both current market leaders and newer startups, nothing is guaranteed. On average, scientists use two to three supplier brands in their laboratories, and a fifth of our respondents said they were highly likely to switch away from their current primary brand in the near future. For companies who produce CRISPR/Cas9 products or provide CRISPR/Cas9 services, this rapid market growth and fluctuation of brand loyalty present a unique opportunity to expand your consumer base by successfully satisfying their needs for effective, quality products and services.

The 2017 Market for CRISPR/Cas9 Genome Editing Products is BioInformatics' third report on this subject. This study provides an in-depth and up-to-date look into scientists' use of this genome editing tool, their toolbox for designing and performing experiments, brand awareness and experience with suppliers, lab budgets and expenditure related to CRISPR/Cas9, and more.

With such a wide range of potential applications and a still-evolving market of suppliers, let us be a strategic guide to your brand and its competition in this quickly growing market.

Table of Contents

Market analytics:

  • Estimated lab size and annual lab budget associated with the purchase of CRISPR/Cas9 products and services
  • Supplier “share of wallet” in terms of laboratory spend for CRISPR/Cas9 products and services
  • Market growth in terms of budget in the next 12 months

Workflow analytics:

  • Years of experience performing genome editing experiments
  • Experimental model systems most often employed
  • Research focus associated with CRISPR/Cas9 genome editing experiments (e.g., diagnostics, therapeutics, basic research, drug discovery)
  • Preferred product configurations for the expression of the Cas9 protein and guide RNAs
  • Definition of what comprises a CRISPR experiment
  • Current level of CRISPR/Cas9 experiments performed and the expected change in throughput in the next 12 months
  • Preferred software solution to design DNA or RNA to generate guide RNAs
  • Molecular transfer methods used to introduce the CAS9 protein and guide RNA formats to the cells/targets of interest
  • Use of novel Cas9 proteins

Brand analytics:

  • Identify awareness and utilization of suppliers of CRISPR/Cas9 products and services
  • Customer satisfaction with suppliers of CRISPR/Cas9 products and services
  • Customer assessment of supplier-specific brand performance

Customer analytics:

  • Motivation for conducting genome editing experiments
  • Customer satisfaction with CRISPR/Cas9 products
  • Customer assessment of supplier-specific CRISPR/Cas9 product performance
  • Likelihood to recommend suppliers of CRISPR/Cas9 products and services
  • Likelihood to repurchase CRISPR/Cas9 products and services
  • Likelihood to switch primary suppliers for CRISPR/Cas9 products and services
  • Motivation for switching primary suppliers
Back to Top